Cited by 14Reproductive Biology and FertilityReproductive Health and TechnologiesOvarian function and disorders

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process

Open access
Courbiere, Blandine, Le Roux, Enora, Mathieu d’Argent, Emmanuelle, Torre, Antoine, Patrat, Catherine, Poncelet, Christophe, Montagut, Jacques, Gremeau, Anne-Sophie, Creux, Hélène, Peigné, Maëliss, Chanavaz-Lacheray, Isabella, Dirian, Lara, Fritel, Xavier, Pouly, Jean-Luc, Fauconnier, Arnaud, on behalf of the PreFerBe Expert Panel·2021·Journal of Clinical Medicine

Published version of a preprint

Abstract

International guidelines are published to provide standardized information and fertility preservation (FP) care for adults and children. The purpose of the study was to conduct a modified Delphi process for generating FP guidelines for BGD. A steering committee identified 42 potential FP practices for BGD. Then 114 key stakeholders were asked to participate in a modified Delphi process via two online survey rounds and a final meeting. Consensus was reached for 28 items. Among them, stakeholders rated age-specific information concerning the risk of diminished ovarian reserve after surgery as important but rejected proposals setting various upper and lower age limits for FP. All women should be informed about the benefit/risk balance of oocyte vitrification—in particular about the likelihood of live birth according to age. FP should not be offered in rASRM stages I and II endometriosis without endometriomas. These guidelines could be useful for gynecologists to identify situations at risk of infertility and to better inform women with BGDs who might need personalized counseling for FP.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm10173810

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 23

  1. Oktay, 2018, Fertility Preservation in Patients with Cancer: ASCO Clinical Practice Guideline Update, J. Clin. Oncol., 36, 1994, 10.1200/JCO.2018.78.1914 · DOI
  2. ESHRE Guideline Group on Female Fertility Preservation, Anderson, R.A., Amant, F., Braat, D., D’Angelo, A., Lopes, S.M.C.d.S., Demeestere, I., Dwek, S., Frith, L., and Lambertini, M. (2020). ESHRE Guideline: Female Fertility Preservation. Hum. Reprod. Open, 2020, hoaa052. · DOI · Paper page
  3. Oktay, 2016, Fertility Preservation in Women with Turner Syndrome: A Comprehensive Review and Practical Guidelines, J. Pediatr. Adolesc. Gynecol., 29, 409, 10.1016/j.jpag.2015.10.011 · DOI
  4. Decanter, 2018, Endometriosis and fertility preservation: CNGOF-HAS Endometriosis Guidelines, Gynecol. Obstet. Fertil. Senol., 46, 368
  5. Lantsberg, 2020, The Role of Fertility Preservation in Women with Endometriosis: A Systematic Review, J. Minim. Invasive Gynecol., 27, 362, 10.1016/j.jmig.2019.09.780 · DOI
  6. Somigliana, 2020, Fertility Preservation in Women with Endometriosis: Speculations Are Finally over, the Time for Real Data Is Initiated, Fertil. Steril., 113, 765, 10.1016/j.fertnstert.2019.12.020 · DOI
  7. Roman, 2018, Endometriosis Surgery and Preservation of Fertility, What Surgeons Should Know, J. Visc. Surg., 155, S31, 10.1016/j.jviscsurg.2018.03.002 · DOI
  8. Stoop, 2016, Oocyte Vitrification for Elective Fertility Preservation: Lessons for Patient Counseling, Fertil. Steril., 105, 603, 10.1016/j.fertnstert.2015.12.044 · DOI
  9. Grynberg, 2019, Fertility Preservation: Should We Reconsider the Terminology?, Hum. Reprod., 34, 1855, 10.1093/humrep/dez160 · DOI
  10. Cobo, 2018, Elective and Onco-Fertility Preservation: Factors Related to IVF Outcomes, Hum. Reprod., 33, 2222, 10.1093/humrep/dey321 · DOI
  11. Grandone, 2018, Venous Thromboembolism in Women Undergoing Assisted Reproductive Technologies: Data from the RIETE Registry, Thromb. Haemost., 118, 1962, 10.1055/s-0038-1673402 · DOI
  12. Doyle, 2016, Successful Elective and Medically Indicated Oocyte Vitrification and Warming for Autologous in Vitro Fertilization, with Predicted Birth Probabilities for Fertility Preservation According to Number of Cryopreserved Oocytes and Age at Retrieval, Fertil. Steril., 105, 459, 10.1016/j.fertnstert.2015.10.026 · DOI
  13. Bafort, 2020, Laparoscopic Surgery for Endometriosis, Cochrane Database Syst. Rev., 10, CD011031
  14. Cobo, 2020, Oocyte Vitrification for Fertility Preservation in Women with Endometriosis: An Observational Study, Fertil. Steril., 113, 836, 10.1016/j.fertnstert.2019.11.017 · DOI · Paper page
  15. Giudice, 2010, Clinical Practice. Endometriosis, N. Engl. J. Med., 362, 2389, 10.1056/NEJMcp1000274 · DOI · Paper page
  16. Schleedoorn, 2019, To Freeze or Not to Freeze? An Update on Fertility Preservation In Females with Turner Syndrome, Pediatr. Endocrinol. Rev., 16, 369
  17. Petersen, 2016, Individual Fertility Assessment and Counselling in Women of Reproductive Age, Dan. Med. J., 63, 1
  18. Hurley, 2018, Postponing Childbearing and Fertility Preservation in Young Professional Women, South. Med. J., 111, 187, 10.14423/SMJ.0000000000000789 · DOI
  19. Dewailly, 2014, The Physiology and Clinical Utility of Anti-Mullerian Hormone in Women, Hum. Reprod. Update, 20, 370, 10.1093/humupd/dmt062 · DOI
  20. Tehrani, 2013, Modeling Age at Menopause Using Serum Concentration of Anti-Mullerian Hormone, J. Clin. Endocrinol. Metab., 98, 729, 10.1210/jc.2012-3176 · DOI
  21. Verschuren, 2015, Added Value of Anti-Müllerian Hormone in Prediction of Menopause: Results from a Large Prospective Cohort Study, Hum. Reprod., 30, 1974, 10.1093/humrep/dev145 · DOI
  22. Lockwood, 2011, Social Egg Freezing: The Prospect of Reproductive “immortality” or a Dangerous Delusion?, Reprod. Biomed. Online, 23, 334, 10.1016/j.rbmo.2011.05.010 · DOI
  23. Devenutto, 2020, In Vitro Activation of Ovarian Cortex and Autologous Transplantation: A Novel Approach to Primary Ovarian Insufficiency and Diminished Ovarian Reserve, Hum. Reprod. Open, 2020, hoaa046, 10.1093/hropen/hoaa046 · DOI

Metadata

Authors
Courbiere, B., Le Roux, E., Mathieu d’Argent, E., Torre, A., Patrat, C., Poncelet, C., Montagut, J., Gremeau, A.-S., Creux, H., Peigné, M., Chanavaz-Lacheray, I., Dirian, L., Fritel, X., Pouly, J.-L., Fauconnier, A., & Panel, O. B. O. T. P. E.
Affiliations
  • Department of Gynecology-Obstetric and Reproductive Medicine, AP-HM, Hôpital La Conception, 13005 Marseille, France
  • Unité d’Epidémiologie Clinique, Hôpital Universitaire Robert Debré, AP-HP Nord-Université de Paris, Inserm, CIC 1426, 75019 Paris, France
  • Department of Gynecology-Obstetric and Reproductive Medicine, GRC6-UPMC, Centre Expert en Endométriose (C3E), Université Pierre-et-Marie-Curie Paris 6, Hôpital Tenon, CHU de Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
  • Department of Gynecology-Obstetric and Reproductive Medicine, CHU Rouen, 37 bd Gambetta, 76000 Rouen, France
  • Inserm (FR)
  • Université Sorbonne Paris Nord (FR)
  • Institut Francophone de Recherche et d’Etudes Appliquées à la Reproduction, Ifreares Toulouse, 31000 Toulouse, France
  • Department of Gynecologic Surgery and IVF, Clermont-Ferrand, University Hospital Clermont-Ferrand, 63000 Clermont-Ferrand, France
  • Clinique Saint Roch, Department of Gynecology-Obstetric and Reproductive Medicine, 34000 Montpellier, France
  • Centre d’Endométriose, Clinique Tivoli Ducos, 33000 Bordeaux, France
  • EndoFrance, Association Française de lutte contre l’Endométriose, 70190 Tresilley, France
  • Department of Gynecology-Obstetric, CH Moulins Yzeure, 03000 Moulins, France
  • Université Paris-Saclay (FR)
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2021-08-25
Volume
10
Issue
17
Pages
3810
ISSN
2077-0383 (ISSN-L)
OpenAlex
W3180791917
Cited by
14
References
2
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 1
FWCI
1.95
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • Preprints.org (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Open Repository and Bibliography (University of Liège) (submittedVersion, other-oa)
Funders
Collège National des Gynécologues et Obstétriciens Français
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Keywords
oocyte vitrification, fertility preservation, benign gynecologic disease, endometriosis, ovarian reserve, benefit-risk balance, endometrioma, infertility risk, Delphi consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review